These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 4624794)

  • 21. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy of pulmonary tuberculosis.
    Johnston RF; Hopewell PC
    Ann Intern Med; 1969 Feb; 70(2):359-67. PubMed ID: 4974415
    [No Abstract]   [Full Text] [Related]  

  • 24. The syndrome of open cavity healing.
    Zierski M
    Scand J Respir Dis Suppl; 1968; 65():151-6. PubMed ID: 4978459
    [No Abstract]   [Full Text] [Related]  

  • 25. A controlled comparison of thiacetazone (thioacetazone) plus isoniazid with PAS plus isoniazid in Hong Kong.
    Tubercle; 1968 Sep; 49(3):243-80. PubMed ID: 4179210
    [No Abstract]   [Full Text] [Related]  

  • 26. A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1980 Sep; 122(3):417-24. PubMed ID: 7416617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity tests.
    Tubercle; 1970 Mar; 51(1):103-5. PubMed ID: 4992975
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1972 May; 1(7760):1079-85. PubMed ID: 4112569
    [No Abstract]   [Full Text] [Related]  

  • 29. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract]   [Full Text] [Related]  

  • 30. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 31. Productivity of prolonged follow-up after chemotherapy for tuberculosis.
    Stead WW; Jurgens GH
    Am Rev Respir Dis; 1973 Aug; 108(2):314-20. PubMed ID: 4198349
    [No Abstract]   [Full Text] [Related]  

  • 32. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M
    Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
    [No Abstract]   [Full Text] [Related]  

  • 34. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
    Yamamoto M; Nakamura H
    Kekkaku; 1971 Jun; 46(6):191-5. PubMed ID: 4997826
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immediate results obtained with intermittent treatment with classical tuberculostatic drugs in tuberculosis in children].
    Tonceanu S; Carp G; Bazacliu E; Sabău I
    Ftiziologia; 1974 May; 23(3):265-8. PubMed ID: 4546327
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of thiacetazone plus isoniazid in Hong Kong: a Hong Kong tuberculosis treatment service-British Medical Research Council investigation.
    Horsfall PA
    Tubercle; 1968 Mar; 49():Suppl:30-2. PubMed ID: 4173325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapeutic studies on advanced tuberculosis in mice].
    Grumbach F
    Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.